Frontiers | A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer
IJMS | Free Full-Text | Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers
Cancers | Free Full-Text | A Novel Urine Exosomal lncRNA Assay to Improve the Detection of Prostate Cancer at Initial Biopsy: A Retrospective Multicenter Diagnostic Feasibility Study
Native Mass Spectrometry Quantitation of α2-3-Linked N-Acetylneuraminic Acid Content of Prostate-Specific Antigen: An Accurate Liquid Biopsy for Clinically Significant Prostate Cancer | Analytical Chemistry
Chemosensors | Free Full-Text | Novel Prostate Cancer Biomarkers: Aetiology, Clinical Performance and Sensing Applications
Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels ≤ 2.0 ng/ml | Prostate Cancer and Prostatic Diseases
Screening and prostate cancer | PPT
Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men | Prostate Cancer and Prostatic Diseases
THE PROSTATE CANCER FOUNDATION CHALLENGES AMERICA TO GET HEALTHY THIS SEPTEMBER
Overall survival and prostate cancer specific-survival according to... | Download Scientific Diagram
NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016 in: Journal of the National Comprehensive Cancer Network Volume 14 Issue 5 (2016)
Prostate Cancer Treatment (PDQ®) - NCI
Profiling the proteoforms of urinary prostate-specific antigen by capillary electrophoresis – mass spectrometry - ScienceDirect
Frontiers | Single-Center Evaluation of Treatment Success Using Two Different Protocols for MRI–Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer
Cancers | Free Full-Text | Derivation and Application of Molecular Signatures to Prostate Cancer: Opportunities and Challenges
Using PSMA imaging for prognostication in localized and advanced prostate cancer | Nature Reviews Urology
A 59-year-old male with newly diagnosed prostate cancer (GS: 4+4, ISUP... | Download Scientific Diagram
Towards the differential diagnosis of prostate cancer by the pre-treatment of human urine using ionic liquids | Scientific Reports
Screening and prostate cancer | PPT
There is current over-treatment of prostate cancer in France - Inserm Newsroom
Cancer de la prostate : l'autotest de nouveau autorisé - AlloDocteurs
Taux de PSA et cancer de la prostate, dépistage
A Nationwide Analysis of Risk of Prostate Cancer Diagnosis and Mortality following an Initial Negative Transrectal Ultrasound Biopsy with Long-Term Followup | Journal of Urology
Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management | Clinical Proteomics | Full Text
